Oxford Asset Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Oxford Asset Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-20,133	Closed	-$32K	–	2050
2017 Q4	$32K	Buy	+20,133	New	+$34.6K	﹤0.01%	1577
2015 Q4	–	Sell	-57,497	Closed	-$2.8M	–	1007
2015 Q3	$2.8M	Buy	57,497 +52,616	+1,078%	+$3.68M	0.09%	238
2015 Q2	$337K	Buy	+4,881	New	+$226K	0.01%	554
2013 Q3	–	Sell	-1,258	Closed	-$37K	–	975
2013 Q2	$37K	Buy	+1,258	New	+$46.9K	﹤0.01%	852

Other funds holding ANTH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Oxford Asset Management's ANTH Position: Q1 2018 in Review

Oxford Asset Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2018, closing a stake of 20,133 shares — an estimated $32K sold.

Oxford Asset Management first reported a position in ANTH in Q2 2013 and held it in 4 quarters. The position peaked at $2.8M in Q3 2015. 28 funds tracked by Wall St. Rank hold ANTH as of Q1 2018.

Oxford Asset Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Oxford Asset Management sold 20,133 Anthera Pharmaceuticals, Inc. shares in Q1 2018, an estimated $32K.
Oxford Asset Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
Oxford Asset Management's Anthera Pharmaceuticals, Inc. position peaked at $2.8M in Q3 2015.
28 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2018.

Based on Oxford Asset Management's 13F filing for Q1 2018, filed 15 May 2018.